News

Investigators from Johns Hopkins examined 16 RCTs to determine efficacy of three anti-VEGF agents for patients with neovascular age-related macular degeneration.

The FDA’s response noted that the onset and duration of intravenous meloxicam would not meet prescriber expectations for an IV drug.

The FDA’s decision regarding sotagliflozin (Zynquista), an investigational treatment for type 1 diabetes, followed a split Advisory Committee vote in January.

The Apple Heart Study examined more than 400,000 patients over the course of a year, but some experts were less than thrilled with the outcomes.

A new long-term data analysis reports that about 50% of patients adhere to the critcal therapy after just 1 year, and the rate continues to drop after that.

Models indicate that a vaccine with just 30% efficacy would significantly reduce HCV transmission if provided to persons at high risk of infection from injecting drugs.

Patients who drank two cans of soda per day were 5 times more likely to have severe symptoms than those who "seldom" consumed it.

The breakthrough device is indicated to improve 6-minute walk distance for certain patients with chronic heart failure.

Study of Danish children finds that onset of maternal mental illness increases a child's risk of not completing primary education.

Disease-modifying therapies for relapsing-remitting MS were shown to reduce risk of conversion to secondary progressive MS.

Until recently, there's been little providers or parents could do, beyond offering supportive care, to improve outcomes for children with SMA. But there is new hope.

Largest birth cohort study to date strengthens link between infant bronchiolitis and later respiratory disease.

A new study of more than 300000 women finds their may be a link between higher BMI at puberty and development of MS.

The applications seek FDA approval for blood sugar control and cardiovascular risk reduction in adults with type 2 diabetes.

Study finds that cardiovascular disease accounts for almost 40% of deaths in young adults with end-stage renal disease.

Little is known on the underlying pulmonary arterial lesions in patients with this phenotype of COPD.

How I became a doctor, lost sight of the joy of practice, and eventually regained my passion to serve my patients.

How soon could support vector machine learning be integrated into a retina specialist’s clinical practice?

The 60-hour intravenous therapy becomes the first drug indicated for postpartum depression.

The oral immunotherapy seeks approval as a treatment to reduce the risk of anaphylaxis in peanut-allergic children and adolescents following exposure to peanut.

Eosinophilic asthma is characterized by elevated levels of eosinophils, which are a direct cause of chronic inflammation in severe asthma.

Flu tracking estimates that don’t consider behavioral differences between different demographic groups will tend to underestimate the spread of the flu, a new study reports.

Patients who received a flu shot had a lower rate of myocardial infarction, according to new research.

The Acticor and Rivacor brands from BIOTRONIK have become the smallest, slimmest 3 Tesla MR-conditional CRM devices on the US market.

FDA approved Rocklatan, a once-daily eye drop produced by Aerie Pharmaceuticals Inc., for patients with open-angle glaucoma or ocular hypertension.

Originally approved in 2013, the MitraClip is now approved for treating certain cases of secondary mitral regurgitation.

First prospective study of direct-acting antiviral treatment of HCV in cancer patients finds that it is safe, efficacious, and that it can open options for chemotherapy.

The Venovo venous stent is the first indicated to treat this condition.